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Bacterial LPS (endotoxin) causes profound physiologic effects in humans and
animals. These include fever, shock, and induction of the acute-phase response
(1). The cell type primarily responsible for these effects is the macrophage which
synthesizes large amounts of IL-1 and cachectin/tumor necrosis factor (TNF) in
response to LPS (2, 3). It is assumed that the high sensitivity to LPS derives from
receptors for LPS on the macrophages. Because LPS is located on the outer
leaflet of the bacterial outer membrane, we hypothesized that receptors for LPS
might mediate the binding of bacteria to macrophages previously observed by
several investigators (4-6). We report here that macrophages bind Escherichia
coli by recognizing LPS.
We have also characterized the receptors responsible for the recognition of E.
coli. It is known that human macrophages express three structurally homologous
receptors, CR3, lymphocyte function-associated antigen (LFA-1),' and p150,95.
Each of these surfaceglycoproteins consists of an a,#, dimer composed ofa 150-
190-kD a chain and a 95-kD0chain. The /3 chain is identical in each of the three
proteins, but the a chains of CR3, LFA-1, and p150,95 are structurally and
antigenically distinct (7, 8). Here we show that each of these dimers can promote
the binding of E. coli to human macrophages.
Materials and Methods
Reagents. Polymyxin B sulfate, chlorpromazine, aprotinin, and yeast mannan were
obtained from Sigma Chemical Co. (St. Louis, MO), 2,4-dinitrophenol from Eastman
Kodak Co. (Rochester, NY), phosphatidylcholine from Supelco, Inc. (Bellefonte, PA),
[3H]phosphatidylcholine (40 mCi/mmol) from New England Nuclear (Boston, MA), and
LPS (Salmonella minnesota R595 [Re]) from List Biological Laboratories (Campbell, CA).
LPS was iodinated with Bolton-Hunter reagent as recommended by the manufacturer
(New England Nuclear), and unbound label was removed by gel filtration. The specific
activity of the product was 1.1 x 104 cpm/,ug. Lipid IVa was a generous gift of Dr. C. R.
H. Raetz (Univ. of Wisconsin, Madison, WI), and ,Q-glucan was a gift of Dr. J. Czop
(Harvard Medical School, Boston, MA).
Antibodies.
￿
Monoclonal antibody (mAb) OKM1, directed against the a chain of CR3
(8), was a gift of Dr. G. Goldstein (Ortho Pharmaceuticals, Raritan, NJ); mAb TS1/22,
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' Abbreviations used in this paper:
￿
HSA, human serum albumin; LFA-1, lymphocyte function-
associated antigen; MO, monocyte-derived macrophage.
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directed against the a chain of LFA-1 (9), was a gift of Dr. T. Springer (Dana-Farber
Cancer Institute, Boston, MA); mAb Leu-M5, directed against the a chain of p150,95
(10) was a gift of Dr. Louis Lanier (Becton, Dickinson & Co., Mountain View, CA); mAb
1134, directed against the (3 chain of CR3, LFA-1, and P150,95 (8), and mAb 3G8, directed
against the low-avidity Fc receptor of neutrophils (11) were as previously described.
Cells.
￿
Human monocytes were purified from huffy coats on Percoll gradients and
were cultured in 12.5% human serum in Teflon beakers as previously described (12).
Upon cultivation for 4-10 d, the cells matured into macrophages (MO). Neutrophils were
purified from fresh human blood on Ficoll-Hypaque gradients (13).
Sheep erythrocytes (E) were coated with C3b (EC3b), C3bi (EC3bi), or IgG (EIgG) as
described (12). E were coated with LPS by a modification of the method of Pangburn et
al. (14). Freshly sonicated dilutions of LPS were incubated for 60 min at 37°C with E at
108 E/ml in an EDTA-containing buffer (5 mM veronal buffer, pH 7 .5, 140 mM NaCl,
0.1% gelatin, 10 mM EDTA). Cells were then washed three times in buffer containing
divalent cations (2 .5 mM veronal buffer, pH 7 .5, 75 mM NaCl, 2 .5% dextrose, 0.06%
gelatin, 0.15 mM CaC12 , 0.5 mM MgC12). In some experiments, radioiodinated LPS was
used and the amount of incorporation into E was directly measured. Uptake varied from
0.5 to 1 .5% of the amount of LPS offered.
Bacteria. E. coli K12 (strain MC1061) was obtained from Dr. D. Portnoy (The
Rockefeller University). Exponentially growing cultures were obtained by innoculating L
broth (1% tryptone, 0.5% yeast extract, 0.15 M NaCI) with a freshly prepared overnight
culture as described (15). Under these growth conditions, our isolate exhibited neither
motility nor the capacity to agglutinate sheep or guinea pig E, thus suggesting that
functional flagella and type I pili were not expressed. Cells were washed three times in
PBS (16) and labeled with FITC by a modification of the method of Hed (17). Bacteria
were suspended to a density of 10' cells/ml in 0 .05 M sodium carbonate, pH 9.2, 0.1 M
NaCl containing 1 mg/ml FITC (Calbiochem-Behring Corp., San Diego, CA). After 15
min incubation at 20°C, the cells were washed three times in PBS. Control experiments
indicated that fluoresceination did not alter the viability of the cultures.
E. coli 0 111B4 GalE and S. typhimurium LT2 GalE were obtained from Dr. R. C.
Goldman (National Institutes of Health, Bethesda, MD). GalE strains lack UDP-glucose
epimerase and thus cannot synthesize galactose (18). In the absence of exogenous galac-
tose, these cells synthesize a truncated, "rough" LPS molecule (see arrow, Fig. 1). Addition
of galactose to cultures of these cells allows the synthesis of wild-type "smooth" LPS (18,
19). Exponentially growing cultures ofthese cells were prepared in L broth to yield rough
bacteria, and parallel cultures were incubated with 100 AM galactose to yield smooth
bacteria. The cells were then washed and labeled with FITC as described above.
Attachment ofBacteria and Ligand-coated Erythrocytes to MO.
￿
Monolayers of phagocytes
were prepared as follows. Cells were suspended at 0.5 x 106 cells/ml (MO) or 2 x 106
cells/ml (neutrophils) in PBS containing 3 mM glucose, 0.5 mg/ml human serum albumin
(HSA; Worthington Biochemical Corp., Freehold, NJ), and 0.3 U/ml aprotinin. Terasaki
tissue culture plates (Miles Laboratories Inc., Naperville, IL) were coated with HSA (1
mg/ml), or with purified mAb (30-50 gg/ml) by a 60-min incubation at 20°C. The
culture surfaces were washed, 5 AI of phagocyte suspension was added per well, and the
cells were allowed to spread at 37 ° C for 45 min .
Attachment of ligand-coated E to monolayers of phagocytes was determined by adding
5 x 105 E/well and incubating for 45 min at 37°C. The attachment of E to phagocytes
was scored by phase-contrast microscopy as previously described (12). Results are reported
as attachment index, the number of E bound per 100 phagocytes. The attachment of
bacteria was measured by adding 2.5 x 105 FITC-labeled bacteria per well . To bring the
bacteria into proximity with the monolayer, the plates were centrifuged at 600 g for 5
min . After an incubation of 30-45 min, unattached bacteria were washed away, and
attachment was scored with the aid of a fluorescence microscope. The fluoresceination
rendered the bacteria readily distinguishable from similarly sized organelles in the MO .
Control experiments in which the binding of bacteria was measured by transmitted-light1878
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microscopy after staining the cells with Wright-Giemsa indicated that the FITC did not
alter the extent or the specificity of the binding.
MO Bind E. coli in the Absence of Serum Opsonins.
￿
Exponentially growing E.
coli K12 were added to monolayers of human MO at a ratio of --50 bacteria per
MO. After 45 min at 37°C, 3-12 bacteria were found adherent to each MO.
The attachment of E. coli to MO was unlikely to be mediated by serum-derived
opsonins because the assay was performed with cells washed into PBS. To rule
out the possibility that anti-E. coli antibodies were carried over into the assay
through interaction with receptors for IgG on the phagocytes (Fc receptors),
MO were cultured for 6 d in the presence of serum that had been adsorbed with
E. coli. Removal of anti-E. coli antibodies had no effect on the attachment of E.
coli (data not shown).
A contribution of Fc receptors to the binding of E. coli was further eliminated
by observing the attachment of bacteria to MO spread on surfaces coated with
IgG in antigen-antibody complexes. After phagocytes spread on such ligand-
coated surfaces, Fc receptors diffuse in the plane of the membrane and are
trapped by interaction with substrate-bound fgand (20, 21). The apical portion
of the MO membrane is thus depleted of receptors. Table I shows that substrate-
bound immune complexes caused significant downmodulation of Fc receptors,TABLE I
Bindingof E. coli by MO Does Not Require Fc Receptors, Secreted Complement Components,
Mannosyl/Fucosyl Receptors, or Mannose-sensitive Adhesins
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Monocytes were cultured for 4 d in Teflon beakers, and monolayer cultures were then established.
The binding of E. coli or the indicated ligand-coated E was then measured in the presence of 50
MM a-D-mannose, 1 mg/ml mannan, or 50 Ag/ml Fab anti-C3 antibody. Data are presented as
attachment index, the number ofparticles attached per 100 phagocytes.
* To remove Fc receptors from theapical surface of the MO, monolayers were formed on substrates
coated with DNP groups and anti-DNP IgG (20). The resulting immune complex-coated surface
withdraws Fc receptorsas indicated by the inhibition of the bindingof EIgG.
in that IgG-coated erythrocytes (EIgG) could no longer bind to the apical portion
of the MO. The binding of E. coli, however, was not affected.
MO synthesize and secrete proteins of the complement cascade, and it has
been suggested that phagocytes may opsonize particles with this endogenous
store (22). To eliminate the possible contribution of MO-derived C3 to the
recognition ofE. coli, bindingassays wereperformed in the presence ofsaturating
concentrations of Fab anti-C3 antibodies. These antibodies completely block the
binding of erythrocytes coated with ^"80,000 C3b or C3bi (Table I). However,
Fab anti-C3 has no effect on the binding of E. coli. It is thus unlikely that auto-
opsonization of E. coli with MO-derived C3 accounts for the observed recogni-
tion.
Several naturally occurring isolates ofE. colipossesspill that recognize mannose
residues on the surfaces of eukaryotic cells, and these adhesins can promote
binding ofbacteria to phagocytes (23, 24). Such mannose-recognizing structures
do not play a role in the recognition described here because concentrations of
mannose thatcompletely block the mannose-sensitive adhesins (50 mM, reference
24) have no effect on the binding ofE. coli (Table I). MO also expressa receptor
for mannose and fucose that participates in the binding of zymosan (25) and
Leishmania (26). This receptor appears not to participate in the recognition ofE.
coli inasmuch as concentrations of yeast mannan that block binding of zymosan
and Leishmania (1 mg/ml mannan) do not inhibit binding of E. coli (Table I).
Finally, MO recognize several particles (rabbit E and neuraminidase-treated
mouse E) that activate the alternative pathway of complement, and this recog-
nition can be blocked with soluble #-glucan (27). The binding of E. coli to MO,
however, is not blocked by 100 Ag/ml (3-glucan, a concentration that is 100-fold
higher than required to block the binding ofalternative pathway activators (data
not shown) . These data suggest that MO recognize E. coli by a novel mechanism
that does not require IgG, complement proteins, adhesins on the bacterial
surface, mannose receptors, or 0-glucan receptors.
The characteristics of the binding of E. coli to MO were studied. Binding
Inhibitor
E. coli EIgG
Attachment index
EC3b EC36i ELPS
None 475 1,014 1,026 1,140 661
Immune complexes* 526 105 1,179 1,135 690
50 mM mannose 453 871 1,350 1,205 693
1 mg/ml mannan 331 1,008 1,013 1,152 698
Fabanti-C3 453 930 49 36 7561880 RECEPTORS FOR LIPOPOLYSACCHARIDE ON MACROPHAGES
Monocytes were cultured for 4 d in Teflon beakers. Monolayers of phagocytes
were then prepared and the cells were washed into PBS made without divalent
cations (PD). The indicated cations were added (0 .5 mM), and the bindingof E.
coli or the indicated ligand-coated E was determined as described in Materials
and Methods. Data are presented as attachment index, the number of particles
attached per 100 phagocytes. Results shown are representative of three separate
experiments.
TABLE III
Temperature Dependence oftheBinding ofE. coli to MO
TABLE II
BindingofE. coli to MO Requires Divalent Cations
Monolayers of MO (7-d cultures) were incubated for 30 min with E. coli
or the indicated ligand-coated E at the temperatures shown, and the
attachment of particles was then determined. Results shown are repre-
sentative of four separate experiments.
required both Ca"and Mg" (Table 11) and occurred only at warm temperatures.
Binding was lowered three- to fivefold when the temperature was reduced to
18°C and was absent at 0°C (Table III). The requirements for divalent cations
and warm temperatures are unlike those for the binding of IgG or C3b-coated
particles (Table III). However, these characteristics closely resemble the require-
ments for binding of C3bi-coated particles to MO (12, and Tables I and II).
Receptors on MO Recognize LPS.
￿
In order to bind live E. coli, receptors on the
phagocyte must recognize an external constituent of the bacterium. Because the
strain of E. coli used in these experiments has neither pili nor flagella, we
examined the most prevalent molecule on the outer membrane, LPS. We first
observed the binding of strains of bacteria with modified LPS. E. coli K12 is
considered a rough strain because its LPS is truncated at the ketodeoxyoctonate-
containing core region and does not bear polymers of sugars that compose the
O antigens (Fig. 1). To observe the role of the O antigen, we compared the
binding of isogenic smooth strains (with O antigen) and rough strains (without
O antigen) of E. coli and S. typhimurium. The presence of O antigen strongly
depressed the nonopsonic recognition of both E. coli and Salmonella to macro-
phages (Table IV). Theseobservations suggest that modification of LPS structure
affects the interaction of E. coli with receptors on the MO.
To further examine the role of LPS in the binding of E. coli, MO were allowed
Divalent cation
E,. coli EC3b
Attachment
EIgG
index
EC3bi ELPS
Ca"and Mg" 765 803 870 1,217 853
Ca2+ 186 796 850 286 300
Mg2` 145 719 850 228 120
None 85 803 781 68 121
Temperature
E. coli EC3bi
Attachment
EIgG
index
EC3b ELPS
37°C 273 1,479 881 1,843 1,800
18°C 54 596 1,009 1,521 80
01C 17 153 1,045 1,456 21WRIGHT AND JONG
TABLE IV
Binding ofGram-negative Bacteria to Human Phagocytes
TABLE V
Smooth and rough preparations of E. coli and S. typhimurium were obtained by
growingGaIE mutants of these strains in the presence or absence of galactose as
described in Materials and Methods. The binding of bacteria to monolayers of
macrophages, monocytes, or neutrophils was then measured. Results are repre-
sentative of threeexperiments.
Inhibition of the Binding of E. coli by Surface-bound LPS
Tissue culture plastic surfaces were coated for 60 min at 37°C with 50
jug/ml of the lipids shown. Surfaces were then incubated for 60 min at
20°C with 1 mg/ml HSA in the presence or absence of 10,uM polymyxin
Bsulfate. Surfaces were then washed and MO (5-d cultures) were allowed
to spread for 45 min. The attachment of E. coli or ligand-coated E was
then measured usinga 30-min assaZ. Control experiments showed that the
tissue culture wells bound 3 X 10 molecules of ['Hl~hosphatidylcholine
per square micrometer and 6 X 105 molecules of 251-LPS per square
micrometer. This density of LPS is approximately equal to that in the
outer membrane of E. coli. Addition of polymyxin did not cause the loss
of lipids from the culture surface.
1881
to spread on surfaces coated with purified rough LPS. These cells exhibited a
marked reduction in the capacity to bind E. coh, whereas the capacity to bind
IgG-coated particles remained unchanged (Table V). By analogy with experi-
ments described above with surface-bound IgG, webelieve that specific receptors
for LPS diffuse to the substrate-attached portion of the phagocyte, where they
are trapped by interaction with surface-bound LPS. Removal of receptors for
LPS thus appears to block the binding of E. coli.
The lipid A portion of LPS appears critical for its interaction with receptors
on MO. Pretreatment of LPS-coated surfaces with polymyxin B sulfate, a drug
that binds the lipid A region, completely abolished their capacity to inhibit the
binding of E. coli (Table V). Further, downmodulation of the binding of E. coli
occurred with a chemically defined biosynthetic precursor of LPS termed lipid
IVa (Table V). Lipid IVa comprises a portion of lipid A (Fig. 1, and reference
Coating of surface
E. coli
Attachment index
EC3bi EIgG
None 1,191 782 412
Rough LPS 318 281 457
Rough LPS + polymyxin 1,044 676 478
Lipid IVa 230 288 389
Lipid IVa + polymyxin 1,209 652 438
Phosphatidylcholine 1,200 696 450
Bacterium
Attachment index
Macrophages Monocytes Neutrophils
E. coli K12 (rough) 559 615 668
E. coli 0111B4, rough 409 460 407
E. coli 0111B4, smooth 25 130 171
S. typhimurium LT2, rough 399 602 418
S. typhimurium LT2, smooth 31 101 361882
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Attachment of ELPS to MO. E were coated with various amounts of 121I-LPS.
Monolayers of MO (7-d cultures) were then established on surfaces coated with HSA (O) or
on surfaces coated with theanti-# mAb, IB4 (A). Thebindingof the ELPS wasthen measured.
The results shown are representative of threeseparate experiments.
28). Surfaces coated with a phospholipid unrelated to LPS, phosphatidylcholine,
caused no depression in E. coli binding (Table V).
To characterize further the ligand specificity of the receptors for LPS, we
observed the binding ofpurified LPS preparations to MO. LPS was allowed to
partition into the membranes of erythrocytes. We believe the LPS becomes
inserted into the bilayer because the addition ofpolymyxin B causes prompt lysis
of LPS-coated erythrocytes (ELPS) but not control E (data not shown) . In this
inserted configuration, the hydrophilic portion of LPS is exposed to the medium
as it is in a bacterial membrane. ELPS bound avidly to MO, and the binding was
dependent on the number of LPS per E (Fig. 2). The binding of ELPS to MO
was not a consequence of deformation of the red cell membrane caused by
inserted lipid. The membrane-active agents, chlorpromazine and 2,4-dinitrophe-
nol, which intercalate into the inner and outer leaflets of the membrane,
respectively (29), caused marked shape changes in the erythrocytes, but did not
enable the E to bind to MO (data not shown).
MO recognize ELPS by the same mechanism used for E. coli. The binding of
ELPS required divalent cations (Table II), and was inhibited at temperatures
lower than 37'C (Table 111). Further experiments indicated that ELPS were
recognized by the same MO receptors as E. coli (see below).
E. coli Are Recognized by CR3, LFA-1, and p150,95.
￿
MO express a family of
heterodimeric cell surface glycoproteins that are involved in adhesion reactions
(for review, see reference 30). CR3 (the C3bi receptor) mediates the binding of
C3bi-coated particles (8), LFA-1 mediates the binding of tumor cells (31), and
the function ofthe thirdprotein, p150,95, has notbeen determined. MO express
approximately equal numbers of these three surface proteins (S. D. Wright,
unpublished observations). The adhesion events mediated by CR3 and LFA-1
are dependent on divalent cations and warm temperatures (12, 32, and Table
111), thus suggesting that these or similar receptors may function in the recogni-
tion of LPS. Our first indication that CR3 binds to LPS was that LPS-coatedTABLE VI
Attachment ofE. coli to MO Is Inhibited by Substrate-bound
Monoclonal Antireceptor Antibodies
WRIGHT AND JONG
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Monocytes were cultured for 7 d in Teflon beakers. Thephagocytes were then
allowed to spread on surfaces coated with the indicated mAb for 45 min at
37'C. ThebindingofE. coli or ligand-coated E wasthen measured usinga 45-
min assay. Results are representative of four separate experiments.
*The mAb 3G8 is directed against the low avidity Fc receptor of neutrophils
and reacts weakly with MO (11).
surfaces reduced the capacity ofMO to bind EC3bi (Table V). This observation
suggests that the C3bi receptor (CR3) also binds LPS.
To assess directly the role of CR3, LFA-1, and p150,95 in the binding of
unopsonized E. coli, MO were plated on surfaces coated with monoclonal anti-
receptor antibodies. We havepreviously demonstrated that such antibody-coated
surfaces cause specific downmodulation of their target antigen from the apical
portion of the MO (8, 33), and experiments with C3bi-coated particles verified
that CR3 wasremovedbyanti-CR3 but not by anti-LFA-1 or anti-p150,95 (Table
VI) under the conditions used here. Removal of all three members of the
CR3/LFA-1/p150,95 family with an antibody against their common ,Q chain
(IB4) caused profound inhibition ofthe binding of E. coli (Table VI), suggesting
thatat least one ofthese receptorsbindsbacteria . Removalofindividual receptors
with antibodies against the apolypeptides, however, caused negligible depression
of binding, and removal of any pair of these receptors caused only modest
inhibition . Profound inhibition of binding was only observed when all three
family members were removed, either using an anti-/3-chain antibody or a
combination ofthree anti-a-chain antibodies. These results indicate that each of
the members of the CR3/LFA-1/p150,95 family is independently capable of
binding E. coli.
All three members of the CR3/LFA-1/p150,95 family appear to recognize
LPS. The binding of ELPS was inhibited when all three of these proteins were
removed from the cell surface, but the binding ofELPS was still observed when
any one of the family members remained on the cell surface (Table VI). We
conclude that the receptors, CR3, LFA-1, and p150,95 can each recognize LPS,
and this binding reaction can result in the attachment of bacteria to MO.
CR3 is found not only on MO but also on monocytes and neutrophils. We
Antibodies on
Ab:OKMI TS1/22
Ag:aCR3 aLFA-1
surface
LeuM5
ap150,95 E.
Attachment
coli ELPS
index
EC3bi
- - - 444 441 700
+ - - 380 420 20
- + - 469 412 570
- - + 452 466 682
+ + - 389 550 32
- + + 521 323 672
+ - + 509 553 42
+ + + 132 52 34
1114 (anti-#) 129 71 56
3G8 (anti-FcR)* 417 512 6221884
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tested whether the expression of these receptors coincides with the ability to
bind E. coh. Each of these cell types bind E. coli (Table IV), and the binding of
each of these cell types is strongly reduced after interaction of the cell with an
1134-coated surface (data not shown).
Discussion
We show here that a family of three structurally related receptors on MO,
CR3, LFA-1, and p150,95, are each capable of recognizing E. coli (Table VI).
Removal ofall three ofthese receptors from the MO membrane halts the binding
of E. coh, but interestingly, removal of any pair of the receptors has negligible
effect on binding. For example, removal of CR3 and LFA-1 from MO does not
reduce the bindingofE. coh. Thus the remaining memberofthe family, p150,95
in this case, is capable ofmediating binding on its own. The capacity to recognize
E. coh, therefore, appears to be a property common to all the members of the
CR3/LFA-1/p150,95 family of receptors.
Our observations strongly suggest that the ligand on E. coli that is recognized
by CR3, LFA-1, and p150,95 is LPS. Red cells coated with purified LPS were
recognized by MO with the identical temperature (Table III), divalent cation
(Table 11), and receptor (Table VI) requirements as E. coh. Further, LPS-coated
surfaces downmodulated the capacity of MO to bind E. coli (Table V).
The site on LPS that is recognized by CR3, LFA-1, and p150,95 appears to
be in the lipid A region of the molecule, in that polymyxin B sulfate blocks the
recognition of LPS (Table V). We have also observed that MO recognize the
biosynthetic precursor of lipid A, termed lipid IVa (Table V, and S. D. Wright,
and C. R. H. Raetz, preliminary observations).
We presume that because CR3, LFA-1, and p150,95 bind to LPS that is
inserted into E. coli membranes or into red cell membranes, the receptors must
bind the hydrophilic portion of the LPS molecule. Inasmuch as the hydrophilic
portion oflipid IVa is composed ofdiglucosamine bisphosphate, we suspect that
a disaccharide or sugar phosphate provides the structure that is recognized. It is
possible that the three proteins, CR3, LFA-1, andpl50,95, each recognize subtly
different residues in order to provide a greater spectrum of target molecules.
CR3, LFA-1, and p150,95 have previously been recognized as receptors that
function in adhesion events. CR3 mediates the binding of C3bi-coated E to MO
(8), LFA-1 mediates adhesion between killer T cells and their targets (9), and
neutrophils from patients deficient in this family of receptors show defects in
chemotaxis and attachment to glass surfaces (34). Recent work further suggests
that all three of these receptors function in the recognition of the fungal
pathogen, Histoplasma capsulatum by MO (35). The experiments described here
show that CR3, LFA-1, and p150,95 also recognize LPS. The recognition of
LPS requires divalent cations (Table 11) and warm temperatures (Table III) as
have all the previously described actions of these receptors. Thus, MO employ a
common mechanism and a common set of receptors to recognize a diverse
spectrum of ligands. The explanation for this broad specificity is not clear. It is
possible that LPS, C3bi, and H. capsulatum display a common structure, such as
a sugar phosphate, that can be recognized by the receptor CR3. Alternatively,
CR3 may contain multiple binding sites with different specificities, as recentlysuggested by Ross et al. (36). Whether a single binding site on CR3 serves both
for the binding of LPS and C3bi or if multiple binding sites exist is currently
under study.
MO can recognize E. coli in the absence of IgG, complement proteins, or
bacterial adhesins. This novel mechanism of recognition may thus serve in the
initial response of cells to bacteria, before the generation of specific immunity.
Consistent with this view are the observations on several patients whose cells lack
the common 0 chain of CR3, LFA-1, and p150,95 and express none of the
mature a,(3, dimers on their cell surface (37). These patients suffer recurrent
bacterial infections (30). The precise role of this recognition system in host
defense, however, remains to be determined. Unopsonized E. coli appears to be
phagocytosed by MO (S. D. Wright, unpublished observations), butthe efficiency
with which the bacteria are subsequently killed has not yet been determined.
The full spectrum of bacterial species that can be recognized nonopsonically is
also not known. We have observed that MO recognize rough strains ofE. coli, S.
typhimurium (Table IV), and Pseudomonas aeruginosa (D. P. Speert and S. D.
Wright, unpublished observations), but smooth strains of E. coli and Salmonella
are recognizedpoorly (Table IV). Since manypathogenic gram-negative bacterial
strains are smooth (18), clearance of these pathogens may require the action of
IgG and complement.
It is of interest that all cell types that express CR3, LFA-1, or p150,95 have
been reported to exhibit a striking physiological response to low levels of LPS:
MO secrete IL-1 and TNF, PMN show enhanced capacity torelease toxic oxygen
intermediates (38), and B lymphocytes undergo blast transformation (39). We
show here that CR3, LFA-1, andp150,95 can act as receptors for LPS. Whether
these receptors directly mediate the biological effects of LPS such as release of
IL-1 is currently under investigation.
Summary
We report here that human macrophages bind Escherichia coli by recognizing
bacterial lipopolysaccharide (LPS). Purified LPS was inserted into erythrocyte
membranes, and the resulting LPS-coated red cells were bound by macrophages
with the same temperature and cation dependence as observed for E. coli. When
receptors for LPS were withdrawn from the plasma membrane by spreading the
macrophages on LPS-coated surfaces, the binding of E. coli was blocked. We
have also identified the receptors on macrophages that recognize LPS. Macro-
phages express three structurally homologous cell surface proteins, CR3, lym-
phocyte function-associated antigen (LFA-1), and p150,95. We used surface-
bound monoclonal antireceptor antibodies to selectively remove these proteins
from the apical surface of macrophages. We found that each of these proteins
mediated the binding of E. coli to macrophages.
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